BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11375781)

  • 1. Role of biotransformation in conceptal toxicity of drugs and other chemicals.
    Kulkarni AP
    Curr Pharm Des; 2001 Jun; 7(9):833-57. PubMed ID: 11375781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA oxidation as a potential molecular mechanism mediating drug-induced birth defects: phenytoin and structurally related teratogens initiate the formation of 8-hydroxy-2'-deoxyguanosine in vitro and in vivo in murine maternal hepatic and embryonic tissues.
    Liu L; Wells PG
    Free Radic Biol Med; 1995 Nov; 19(5):639-48. PubMed ID: 8529923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochromes P450 in the bioactivation of chemicals.
    Ioannides C; Lewis DF
    Curr Top Med Chem; 2004; 4(16):1767-88. PubMed ID: 15579107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative damage in chemical teratogenesis.
    Wells PG; Kim PM; Laposa RR; Nicol CJ; Parman T; Winn LM
    Mutat Res; 1997 Dec; 396(1-2):65-78. PubMed ID: 9434860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of biotransformation and bioactivation in toxicity.
    Dekant W
    EXS; 2009; 99():57-86. PubMed ID: 19157058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-cytochrome P450-mediated bioactivation and its toxicological relevance.
    Gan J; Ma S; Zhang D
    Drug Metab Rev; 2016 Nov; 48(4):473-501. PubMed ID: 27533622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial Biotransformation of Drugs and other Xenobiotics.
    Orhan H; Karakuş F; Ergüç A
    Curr Drug Metab; 2021; 22(8):657-669. PubMed ID: 34182906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of xenobiotic biotransformation including reactive oxygen species generation in the embryo using benzene as an example.
    Renaud HJ; Rutter A; Winn LM
    Methods Mol Biol; 2012; 889():253-63. PubMed ID: 22669669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.
    Pirmohamed M; Madden S; Park BK
    Clin Pharmacokinet; 1996 Sep; 31(3):215-30. PubMed ID: 8877251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug metabolism by the human fetus.
    Juchau MR; Chao ST; Omiecinski CJ
    Clin Pharmacokinet; 1980; 5(4):320-39. PubMed ID: 6994979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idiosyncratic toxicity: the role of toxicophores and bioactivation.
    Williams DP; Park BK
    Drug Discov Today; 2003 Nov; 8(22):1044-50. PubMed ID: 14690635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxidases: a role in the metabolism and side effects of drugs.
    Tafazoli S; O'Brien PJ
    Drug Discov Today; 2005 May; 10(9):617-25. PubMed ID: 15894226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450-dependent bioactivation of prodysmorphogens in cultured conceptuses.
    Juchau MR; Harris C; Stark KL; Lee QP; Yang HY; Namkung MJ; Fantel AG
    Reprod Toxicol; 1991; 5(3):259-63. PubMed ID: 1807561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Xenobiotic metabolism in humans during early pregnancy: peroxidase-mediated oxidation and bioactivation of 2-aminofluorene.
    Kulkarni AP; Murthy KR
    Xenobiotica; 1995 Aug; 25(8):799-810. PubMed ID: 8779222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical toxicology of chemical teratogenesis.
    Wells PG; Winn LM
    Crit Rev Biochem Mol Biol; 1996 Feb; 31(1):1-40. PubMed ID: 8744954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conventional and novel approaches in generating and characterization of reactive intermediates from drugs/drug candidates.
    Orhan H; Vermeulen NP
    Curr Drug Metab; 2011 May; 12(4):383-94. PubMed ID: 21395525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactions and enzymes in the metabolism of drugs and other xenobiotics.
    Testa B; Pedretti A; Vistoli G
    Drug Discov Today; 2012 Jun; 17(11-12):549-60. PubMed ID: 22305937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioactivation of drugs: risk and drug design.
    Walsh JS; Miwa GT
    Annu Rev Pharmacol Toxicol; 2011; 51():145-67. PubMed ID: 21210745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of 13-cis- and 9-cis-retinoic acid to all-trans-retinoic acid in rat conceptal homogenates. Evidence for catalysis by a conceptal isomerase.
    Chen H; Juchau MR
    Drug Metab Dispos; 1998 Mar; 26(3):222-8. PubMed ID: 9492384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics.
    Kalgutkar AS; Dalvie DK; O'Donnell JP; Taylor TJ; Sahakian DC
    Curr Drug Metab; 2002 Aug; 3(4):379-424. PubMed ID: 12093357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.